He S-X, Xiong L-L, Yao S-S, et al. The preclinical research of high intensity focused ultrasound. J Beijing Med Univ. 1999;31:573–6.
Dubinsky TJ, Cuevas C, Dighe MK, et al. High-intensity focused ultrasound: current potential and oncologic applications. AJR Am J Roentgenol. 2008;190:191–9.
Hutchinson L. Treatment modalities: HIFU is effective for unresectable HCC. Nat Rev Clin Oncol. 2011;8:385.
Cheung TT, Ma KW, She WH. A review on radiofrequency, microwave and high-intensity focused ultrasoundablations for hepatocellular carcinoma with cirrhosis. Hepatob Surg Nutr. 2021;10:193–209.
Sofuni A, Moriyasu F, Itoi T, et al. The current potential of high-intensity focused ultrasound for pancreatic carcinoma. J Hepatob Pancreat Sci. 2011;18:295–303.
Sofuni A, Asai Y, Tsuchiya T, et al. Novel therapeutic method for unresectable pancreatic cancer-the impact of the long-term research in therapeutic effect of high-intensity focused ultrasound (HIFU) therapy. 2021;28:4845–61.
Sofuni A, Asai Y, Mukai S, et al. High-intensity focused ultrasound therapy for pancreatic cancer. J Med Ultrason. 2022. https://doi.org/10.1007/s10396-022-01208-4.
Sofuni A, Asai Y, Tsuchiya T, et al. Novel therapeutic method for unresectable pancreatic cancer-the impact of the long-term research in therapeutic effect of high-intensity focused ultrasound (HIFU) therapy. Curr Oncol. 2021;28:4845–61.
Article PubMed PubMed Central Google Scholar
Wang YB, Ma R, Wang ZB, et al. Transcatheter arterial chemoembolization in combination with high-intensity focused ultrasound for intermediate and advanced hepatocellular carcinoma: a meta-analysis. Front Oncol. 2022;12: 797349.
Article PubMed PubMed Central Google Scholar
You Y, Wang Z, Ran H, et al. Nanoparticle-enhanced synergistic HIFU ablation and transarterial chemoembolization for efficient cancer therapy. Nanoscale. 2016;8:4324–39.
Article CAS PubMed Google Scholar
Zhang Q, Wang Y, Zhang J, et al. TACE combined with HIFU versus surgical resection for single hepatocellular carcinoma with Child-Pugh B cirrhosis in overall survival and progression-free survival: a retrospective study. Technol Cancer Res Treat. 2021;20:15330338211060180.
Article CAS PubMed PubMed Central Google Scholar
Shen HP, Gong JP, Zuo GQ. Role of high-intensity focused ultrasound in treatment of hepatocellular carcinoma. Am Surg. 2011;77:1496–501.
Cheung TT, Chu FS, Jenkins CR, et al. Tolerance of high-intensity focused ultrasound ablation in patients with hepatocellular carcinoma. World J Surg. 2012;36:2420–7.
Article PubMed PubMed Central Google Scholar
Ng KK, Poon RT, Chan SC, et al. High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience. Ann Surg. 2011;253:981–7.
Barrere V, Sanchez M, Cambronero S, et al. Evaluation of ultrasonic attenuation in primary and secondary human liver tumors and its potential effect on high-intensity focused ultrasound treatment. Ultrasound Med Biol. 2021;47:1761–74.
Daunizeau L, Nguyen A, Le Garrec M, et al. Robot-assisted ultrasound navigation platform for 3D HIFU treatment planning: initial evaluation for conformal interstitial ablation. Comput Biol Med. 2020;124: 103941.
Article CAS PubMed Google Scholar
Fukuda H, Ito R, Ohto M, et al. Treatment of small hepatocellular carcinomas with US-guided high-intensity focused ultrasound. Ultrasound Med Biol. 2011;37:1222–9.
Tsang SH, Ma KW, She WH, et al. High-intensity focused ultrasound ablation of liver tumors in difficult locations. Int J Hyperthermia. 2021;38:56–64.
Article CAS PubMed Google Scholar
Chen X, Ma Y, Zhang J, et al. Evaluating the long-term survival benefits of high intensity focused ultrasoundablation for hepatocellular carcinoma with portal vein tumor thrombus: a single center retrospective study. Int J Hyperthermia. 2022;39:1245–53.
Gu L, Shen Z, Ji L, et al. High-intensity focused ultrasound alone or combined with transcatheterarterial chemoembolization for the treatment of hepatocellular carcinomawith unsuitable indications for hepatectomy and radiofrequency ablation: a phase II clinical trial. Surg Endosc. 2022;36:1857–67.
Hu J, Mao H, He Y. Systematic review and meta-analysis of the efficacy and safety of high-intensity focused ultrasound combined with transarterial chemoembolization and transarterial chemoembolization alone in the treatment of liver cancer. Transl Cancer Res. 2022;11:1678–88.
Article CAS PubMed PubMed Central Google Scholar
Sehmbi AS, Froghi S, Andrade MO, et al. Systematic review of the role of high intensity focused ultrasound (HIFU) in treating malignant lesions of the hepatobiliary system. HPB (Oxf). 2021;23:187–96.
Kim J, Chung DJ, Jung SE, et al. Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoembolisation for hepatocellular carcinoma < 5 cm: comparison with transarterial chemoembolisation monotherapy-preliminary observations. Br J Radiol. 2012;85:e940–6.
Article CAS PubMed PubMed Central Google Scholar
Cheung TT, Fan ST, Chan SC, et al. High-intensity focused ultrasound ablation: an effective bridging therapy for hepatocellular carcinoma patients. World J Gastroenterol. 2013;19:3083–9.
Article PubMed PubMed Central Google Scholar
Cheung TT, Poon RT, Jenkins CR, et al. Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas. Liver Int. 2014;34:e136-43.
Wu F, Wang ZB, Chen WZ, et al. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology. 2005;235:659–67.
Li C, Zhang W, Zhang R, et al. Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma. Eur J Cancer. 2010;46:2513–21.
Cui L, Liu XX, Jiang Y, et al. Comparative study on transcatheter arterial chemoembolization, portal vein embolization and high intensity focused ultrasound sequential therapy for patients. Asian Pac J Cancer Prev. 2012;13:6257–61.
Chan AC, Cheung TT, Fan ST, et al. Survival analysis of high-intensity focused ultrasound therapy versus radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma. Ann Surg. 2013;257:686–92.
Zou YW, Ren ZG, Sun Y, et al. The latest research progress on minimally invasive treatments for hepatocellular carcinoma. Hepatob Pancreat Dis Int. 2023;22:54–63.
Diana M, Schiraldi L, Liu YY, et al. High intensity focused ultrasound (HIFU) applied to hepato-bilio-pancreatic and the digestive system-current state of the art and future perspectives. Hepatob Surg Nutr. 2016;5:329–44.
Wu L, Zhou J, Zhou W, et al. Sorafenib blocks the activation of the HIF-2α/VEGFA/EphA2 pathway, and inhibits the rapid growth of residual liver cancer following high-intensity focused ultrasound therapy in vivo. Pathol Res Pract. 2021;220: 153270.
Article CAS PubMed Google Scholar
Numata K, Fukuda H, Ohto M, et al. Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent. Eur J Radiol. 2010;75:e67-75.
Comments (0)